Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
about
Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoterRegulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-betaProtein C replacement in severe meningococcemia: rationale and clinical experience.Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitro.Plasminogen activator inhibitor in the blood of patients with coronary artery disease.Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cellsRegulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.cDNA cloning of human plasminogen activator-inhibitor from endothelial cellsThe addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expressionEndothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-alphaCellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissueInhalation of a Short-Acting β2-Adrenoreceptor Agonist Induces a Hypercoagulable State in Healthy Subjects.Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells.Effect of polymyxin B and colimycin on induction of plasminogen antiactivator by lipopolysaccharide in human endothelial cell culture.Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteriesDistribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.Assessment of endothelial dysfunction.Pathogenesis of postoperative adhesion formation.Influence of delivery on plasminogen activator inhibitor activity.Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease.Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages.The status of plasminogen activator inhibitor-1 as a therapeutic target.Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.Extracellular accumulation of bioactive substances; interleukin-1beta (IL-1beta) and plasminogen activator inhibitor-1 (PAI-1) in stored blood units and relation to bacterial contamination.Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy.Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).Functional stability of plasminogen activator inhibitor-1
P2860
Q33635406-33D696FD-A531-49FD-AD10-5B2D64CB05AAQ34205401-C26250CB-6894-45DF-B486-38F99C0A1F5EQ34219618-95B85C2C-A870-48E1-B203-80BC9DBD78CDQ34220031-70CD0E3F-3F21-442C-831F-79F84E9D2523Q34490676-608608CD-E912-47A8-8A7A-7FD42DE0E343Q34518795-F74314B0-4C7B-4C8B-A394-B077C8B31A3AQ34534987-E664A907-6FC2-449E-836A-B1FAC659CC59Q34551601-D7192008-48D0-4381-996C-834487AB6347Q34559926-78FB11E1-070B-470E-BADD-C23648383B6DQ35059478-96775C8F-318B-4B54-915D-8270A6B05AB2Q35580262-3192C2FE-7B74-42ED-8B95-A6AC90943403Q35764729-21880FA9-D9CC-4BE2-A962-6F24B7A6F594Q35832540-4E98A800-B17A-4AD0-91A0-7F812A4CC0EEQ36068244-B74CB98E-C1B5-4BED-826A-8FBF974B28D7Q36072526-A47AE240-E317-4CE9-9B4E-125DDE6DE69AQ36217085-541835EC-D1C4-4107-9C1F-C79785BC77D0Q36986388-1D3F1E61-0D19-4AC1-B4E8-1DF13FE015D4Q37027295-98DF450A-EE6E-47B3-B918-1BC032FC7F28Q37131350-1611869E-18B5-49C5-BFD1-9635E6832B7FQ37350905-760B8B56-3981-4EF1-AA4F-ACE5992F89CEQ37732250-F3E5C9A0-F412-4F1D-A4FD-11E27223B974Q37923882-A4A62176-DE6B-4B0F-B289-AADCB6361AE7Q38713670-D02E9CF2-ADA6-4F05-9A0C-7E5B136D85F1Q39561337-52F69CE1-9886-4FDD-93F1-8E3C80E3EB45Q40305997-D0669625-069E-4CA7-B770-1A66C732729EQ40510642-AD1A91E7-BCB2-408C-A182-B3F12791276AQ40530719-065F6A42-D554-457D-9F4E-BCB6830DB302Q40743945-692B7FEF-2E4E-48D5-8572-818AF08E186FQ40853251-B0C10304-62C3-4652-A781-11FDAEC8CD48Q40894566-FD08E0AC-37C9-4651-B483-B577317747E4Q40920385-7AA4D723-C700-445C-94BC-D8DAB1111723Q41450891-C4F94A91-F46B-4F97-9CE0-1B5F33384B18Q41780622-86A2D768-EB67-403B-A89A-074AF52D3B66Q42588928-C01A4771-D993-43FB-85C1-2D04F773EB18Q42752391-0F4CA415-6CA3-427E-B6DA-6204D6405246Q42754410-209A4389-489A-4B5C-BEDA-CCA9501E9C80Q54038662-99B8AF7B-D245-436A-B2EC-98CC260A9FF8Q59101064-AB66D45E-8650-447C-921A-3288D8004AB7
P2860
Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.
description
1985 nî lūn-bûn
@nan
1985 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի մարտին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@ast
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@en
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@nl
type
label
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@ast
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@en
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@nl
prefLabel
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@ast
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@en
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@nl
P2093
P2860
P356
P1476
Generation in plasma of a fast ...... onse to endotoxin stimulation.
@en
P2093
P2860
P304
P356
10.1172/JCI111777
P407
P577
1985-03-01T00:00:00Z